Physiology of ClC-K2/b Cl- channel in the collecting duct

集合管中 ClC-K2/b Cl-通道的生理学

基本信息

项目摘要

Abundant basic and clinical evidence identify a critical role of the augmented epithelial Na+ channel (ENaC) mediated reabsorption in the collecting duct (CD) principal cells in the pathology of salt-sensitive and Angiotensin II (Ang II)-dependent hypertension. On the contrary, aldosterone-mediated increases in ENaC activity during hyperkalemia are necessary to stimulate potassium secretion with no sign of volume retention. Here, we propose that the unique mosaic structure of the CD, consisting of electrically uncoupled principal and intercalated cells, is instrumental for separate control of Na+, K+ and Cl- fluxes to determine its transport profile from volume retention (Na+ and Cl- reabsorption) to Na+/K+ exchange (coupling Na+ reabsorption to K+ secretion). We further generated strong preliminary evidence supporting essential role of ClC-K2/b channel mediated Cl- flux in intercalated cells in this process. Using freshly isolated murine CDs, we found that ClC-K2/b activity and expression is inversely related to dietary Cl- but not K+ intake. Moreover, Ang II exhibits multicomponent stimulatory effects on ClC-K2/b activity, trafficking and channel abundance in the CD intercalated cells implicating its important role in ClC-K2/b activation during low Cl- diet and volume depletion. Consistently, mice lacking Angiotensin type 1 receptors (AT1R) are hypovolemic and have reduced renal ClC-K2/b expression. Overall, we hypothesize that ClC-K2/b function in intercalated cells is primarily regulated by dietary Cl- intake likely in an Ang II-dependent manner. This discretional anionic ClC-K2/b-mediated Cl- influx reduces the ENaC- generated driving force for K+ secretion enabling to tune CD transport profile from Na+/K+ exchange during hyperkalemia (only aldosterone is elevated) to NaCl reabsorption during hypovolemia (both aldosterone and Ang II are increased). Concomitant over-stimulation of ENaC and ClC-K2/b shifts the CD operation to NaCl reabsorptive mode, thereby contributing to the pathology of Ang II-induced hypertension. To address this central hypothesis, we developed 3 specific aims: SA1: Examine regulation of ClC-K2/b activity and expression in the CD by dietary cues. Establish the contribution and supremacy of Ang II and aldosterone in this process. SA2: Define the mechanism of action and delineate the cellular signaling pathway of Ang II regulation of ClC- K2/b activity in the CD. SA3: Establish pathophysiological ramifications of augmented ClC-K2/b activity in the CD in the pathology of Ang II-dependent hypertension using transgenic mice with targeted channel deletion. In summary, this proposal seeks to greatly expand our understanding how electrolyte transport in principal and intercalated cells integrate for proper CD response to dietary and endocrine inputs. Moreover, it also provides physiologically relevant means to target ClC-K2/b-dependent Cl- reabsorption in the CD as a tool to fight salt-sensitive and Ang II-dependent hypertension in clinical setting.
大量的基础和临床证据证实了增强型上皮Na+通道(ENaC)的重要作用 盐敏感性和血管紧张素病理学中集合管(CD)主细胞介导的重吸收 II(Ang II)依赖性高血压。与此相反,醛固酮介导的ENaC活性增加, 高钾血症是刺激钾分泌所必需,而没有容量保留的迹象。在此,我们建议 CD的独特镶嵌结构,由电性未偶联的主细胞和插入细胞组成, 用于分别控制Na+、K+和Cl-通量以确定其从体积的传输轮廓 Na +/K+交换(Na+重吸收与K+分泌耦合)。我们进一步 产生了强有力的初步证据,支持ClC-K2/B通道介导的Cl-通量在 细胞在这个过程中。使用新鲜分离的鼠CD,我们发现ClC-K2/B活性和 表达与膳食Cl-而不是K+摄入量呈负相关。此外,Ang II表现出多组分 对CD插入细胞中ClC-K2/B活性、运输和通道丰度的刺激作用 暗示其在低Cl-饮食和容量消耗期间ClC-K 2/B活化中的重要作用。一致性,小鼠 缺乏血管紧张素1型受体(AT 1 R)的人是低血容量的,并且具有降低的肾C1 C-K2/B表达。 总的来说,我们假设在闰细胞中ClC-K2/B的功能主要受饮食中Cl-摄入的调节 可能是以血管紧张素II依赖的方式。这种任意阴离子ClC-K2/b介导的Cl-内流降低了ENaC- 产生K+分泌的驱动力,使得能够在过程中从Na+/K+交换调节CD转运谱 高钾血症(仅醛固酮升高)对低血容量期间NaCl重吸收(醛固酮和Ang 二是增加)。同时过度刺激ENaC和ClC-K2/B b使CD操作转移到NaCl 重吸收模式,从而有助于血管紧张素II诱导的高血压的病理。为了解决这个中心问题, 假设,我们制定了3个具体目标: SA 1:检查饮食提示对CD中ClC-K 2/B活性和表达的调节。建立 血管紧张素II和醛固酮在这一过程中的贡献和优势。 SA 2:定义作用机制并描述Ang II调节ClC的细胞信号通路- CD中的K2/B活性。 SA 3:确定病理学中CD中ClC-K2/B活性增强的病理生理学后果 使用靶向通道缺失的转基因小鼠研究血管紧张素II依赖性高血压。 总之,该建议旨在大大扩展我们对电解质转运原理的理解, 和嵌入细胞整合,以适当的CD响应饮食和内分泌输入。而且还 提供了生理学相关的手段,靶向CD中的ClC-K2/b依赖性Cl-重吸收,作为一种工具, 在临床环境中对抗盐敏感性和Ang II依赖性高血压。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Oleh Pochynyuk其他文献

Oleh Pochynyuk的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Oleh Pochynyuk', 18)}}的其他基金

Physiology of ClC-K2/b Cl- channel in the collecting duct
集合管中 ClC-K2/b Cl-通道的生理学
  • 批准号:
    10655460
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:
Physiology of ClC-K2/b Cl- channel in the collecting duct
集合管中 ClC-K2/b Cl-通道的生理学
  • 批准号:
    10440429
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:
Physiology of ClC-K2/b Cl- channel in the collecting duct
集合管中 ClC-K2/b Cl-通道的生理学
  • 批准号:
    10018019
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:
Regulation of K+ balance by distal nephron TRPV4 channel
远端肾单位 TRPV4 通道对 K 平衡的调节
  • 批准号:
    10439631
  • 财政年份:
    2018
  • 资助金额:
    $ 35.1万
  • 项目类别:
Regulation of K+ balance by distal nephron TRPV4 channel
远端肾单位 TRPV4 通道对 K 平衡的调节
  • 批准号:
    10203950
  • 财政年份:
    2018
  • 资助金额:
    $ 35.1万
  • 项目类别:
Aldosterone-independent regulation of ENaC by systemic salt
全身盐对 ENaC 的不依赖醛固酮的调节
  • 批准号:
    8726381
  • 财政年份:
    2012
  • 资助金额:
    $ 35.1万
  • 项目类别:
Aldosterone-independent regulation of ENaC by systemic salt
全身盐对 ENaC 的不依赖醛固酮的调节
  • 批准号:
    9125808
  • 财政年份:
    2012
  • 资助金额:
    $ 35.1万
  • 项目类别:
Aldosterone-independent regulation of ENaC by systemic salt
全身盐对 ENaC 的不依赖醛固酮的调节
  • 批准号:
    8540426
  • 财政年份:
    2012
  • 资助金额:
    $ 35.1万
  • 项目类别:
Aldosterone-independent regulation of ENaC by systemic salt
全身盐对 ENaC 的不依赖醛固酮的调节
  • 批准号:
    8908002
  • 财政年份:
    2012
  • 资助金额:
    $ 35.1万
  • 项目类别:
Aldosterone-independent regulation of ENaC by systemic salt
全身盐对 ENaC 的不依赖醛固酮的调节
  • 批准号:
    8387672
  • 财政年份:
    2012
  • 资助金额:
    $ 35.1万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了